Genetic Basis of Hypersusceptibility to Protease Inhibitors and Low Replicative Capacity of Human Immunodeficiency Virus Type 1 Strains in Primary Infection

The initial virus strains from as many as 12% of individuals with primary human immunodeficiency virus (HIV) infection have a 50% inhibitory concentration ≤0.4-fold that of HIV type 1(NL4-3) (HIV-1(NL4-3)) to ritonavir (hypersusceptibility [HS]). There is also substantial variation in replicative ca...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন

প্রকাশিত:	J Virol
প্রধান লেখক:	Leigh Brown, Andrew J., Frost, Simon D. W., Good, Benjamin, Daar, Eric S., Simon, Viviana, Markowitz, Martin, Collier, Ann C., Connick, Elizabeth, Conway, Brian, Margolick, Joseph B., Routy, Jean-Pierre, Corbeil, Jacques, Hellmann, Nicholas S., Richman, Douglas D., Little, Susan J.
বিন্যাস:	Artigo
ভাষা:	Inglês
প্রকাশিত:	American Society for Microbiology (ASM) 2004
বিষয়গুলি:	Vaccines and Antiviral Agents
অনলাইন ব্যবহার করুন:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC369210/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14963120/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.5.2242-2246.2004
ট্যাগগুলো:	ট্যাগ যুক্ত করুন কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!